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Abstract
Background: As differences in gas exchange between pulmonary arterial hypertension (PAH) and chronic
thromboembolic pulmonary hypertension (CTEPH) have been demonstrated, we asked if cardiac output
measurements determined by acetylene (C2H2) uptake significantly differed in these diseases when compared to
the thermodilution technique.
Method: Single-breath open-circuit C2H2 uptake, thermodilution, and cardiopulmonary exercise testing were
performed in 72 PAH and 32 CTEPH patients.
Results: In PAH patients the results for cardiac output obtained by the two methods showed an acceptable
agreement with a mean difference of -0.16 L/min (95% CI -2.64 to 2.32 L/min). In contrast, the agreement was
poorer in the CTEPH group with the difference being -0.56 L/min (95% CI -4.96 to 3.84 L/min). Functional dead
space ventilation (44.5 ± 1.6 vs. 32.2 ± 1.4%, p < 0.001) and the mean arterial to end-tidal CO2 gradient (9.9 ± 0.8
vs. 4.1 ± 0.5 mmHg, p < 0.001) were significantly elevated among CTEPH patients.
Conclusion: Cardiac output evaluation by the C2H2 technique should be interpreted with caution in CTEPH, as
ventilation to perfusion mismatching might be more relevant than in PAH.
Keywords: Pulmonary arterial hypertension, Chronic thromboembolic pulmonary hypertension, Cardiac output, Sin-
gle-breath open-circuit acetylene uptake, Thermodilution
Introduction
The assessment of cardiac output is a crucial factor in
the risk stratification and management of patients with
pulmonary hypertension (PH)a si ti sd i r e c t l yr e l a t e dt o
the clinical severity of the disease as well as being one
of the most important prognostic factors [1].
Several methods have been introduced to measure
cardiac output in humans. The thermodilution techni-
que has been validated against the direct Fick method,
which represents the “gold standard” when evaluating
cardiac output [2]. It is used routinely to assess cardiac
output in PH patients. However, the thermodilution
method is an invasive technique requiring right heart
catheterization of the patient. A reliable non-invasive
method to determine the cardiac output would allow
serial measurements and, thus, would facilitate the fol-
low-up management of PH patients. Among the non-
invasive techniques the acetylene (C2H2)r e b r e a t h i n g
method has been validated against different other tech-
niques and has gained wide acceptance [2-4]. A draw-
back to the method, however, is the build-up of carbon
dioxide (CO2) as a result of rebreathing. Therefore,
open-circuit methods have been developed [5,6]. C2H2
is a non-toxic, inert gas that has a low solubility in lung
tissue but a high solubility in blood. When inhaled,
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a tar a t ep r o p o r t i o n a lt ot h ee f f e c t i v ep u l m o n a r yb l o o d
flow. The rate of disappearance allows calculating the
cardiac output in the absence of a relevant pulmonary
shunt blood flow. Yet, this technique is expected to fail
whenever there are conditions that may affect the distri-
bution of the gas in the lungs. The alveolar distribution
of C2H2 should not be affected in PH patients. However,
significant differences in gas exchange between pulmon-
ary arterial hypertension (PAH) and chronic throm-
boembolic pulmonary hypertension (CTEPH) have been
demonstrated recently, most likely resulting from differ-
ent lung perfusion patterns and additional thromboem-
bolic vascular occlusion in CTEPH [7].
We therefore aimed to clarify if cardiac output mea-
surements done by a single-breath open-circuit C2H2
uptake method significantly differ in PAH and CTEPH
patients when compared to the cardiac output assess-
ment performed by thermodilution.
Materials and Methods
Study design and study population
This retrospective cohort study included patients who
were referred to our PH centre between January 2007
and December 2010. All study participants fulfilled the
diagnostic criteria for PAH or CTEPH according to cur-
rent guidelines [1]. All patients underwent right heart
catheterization to establish the diagnosis. CTEPH was
ruled out or confirmed by ventilation/perfusion scan or
pulmonary angiography in every patient. No subject in
the study received any specific pulmonary artery medi-
cation upon inclusion in the trial. Most of our study
participants were referred to our hospital for the evalua-
tion of PH or unexplained dyspnea on exertion. There-
fore, all patients were extensively diagnosed for the
presence of lung disease. Patients with pulmonary
comorbidity (such as asthma, chronic obstructive pul-
monary disease, lung fibrosis or other symptomatic
interstitial lung diseases) or concomitant extra-cardiac
diseases limiting exercise performance were excluded.
The catheter examination was part of the routine diag-
nostic work-up in all patients. All procedures adhered
to commonly accepted ethical guidelines and written
informed consent was obtained from every patient.
Lung Function Tests
Pulmonary function tests included spirometry, body
plethysmography and measurement of diffusing capacity
employing the single-breath method (Master Screen
Body and MS-PFT, Jaeger, Cardinal Health, USA). Each
parameter was calculated as percentage of the predicted
one. The following parameters were measured: forced
vital capacity (FVC), total lung capacity (TLC), forced
expiratory volume in one second (FEV1) and diffusing
capacity for carbon monoxide (TLco). Blood gas analysis
(ABL 725, Radiometer, Copenhagen, Denmark) was per-
formed in arterialized capillary blood from the ear lobe
without supplemental oxygen (O2).
Cardiopulmonary exercise testing
Cardiopulmonary exercise testing (CPET) was per-
formed using a standardized protocol [6]. Work rate
was continuously increased by 5 - 15 watts/min to a
maximum tolerated level on an electromagnetically
braked cycle ergometer (ViaSprint 150 p, Ergoline, Ger-
many). Patients were encouraged to exercise until symp-
toms were intolerable. Blo o dg a sa n a l y s i sw a sd o n ea t
rest and during peak exercise. Heart rate was monitored
continuously and non invasive blood pressure was taken
every 2 minutes. The maximum work rate was recorded.
O2 uptake (VO2), minute ventilation (Ve) and CO2 out-
put (VCO2) were measured breath by breath using an
adult facemask (Vmax spectra 229 D, Sensor Medics,
USA). O2 pulse, alveolar-arterial O2 difference (AaDO2)
and functional dead space ventilation (Vd/Vt) were cal-
culated as described by Wasserman et al. [8]. The anae-
robic threshold (AT) was chosen at the peak VO2 at
which the ventilatory equivalent for O2 (Ve/VO2)
increased while the ventilatory equivalent for CO2 (Ve/
VCO2) decreased or remained constant. Peak VO2 was
defined as the value of averaged data during the final 15
seconds of exercise. The Ve/VCO2 slope was deter-
m i n e da st h el i n e a rr e g r e s s i o ns l o p eo fV ea n dV C O 2
from the start of exercise until the respiratory compen-
sation point (the time point at which ventilation is sti-
mulated by acidaemia and the end-tidal CO2 (etCO2)
begins to decrease).
Right heart catheterization and thermodilution
Patients received no medication on the morning of the
procedure, resulting in a discontinuation of treatment of
at least 12 hours. A thermodilution catheter (7.5 F
quadruple-lumen, balloon-tipped, flow-directed, “S” Tip
Swan-Ganz Catheter, Edwards Lifesciences, Irvine, USA)
was inserted via the right or left femoral vein. Hemody-
namic measurements were performed in supine position
and included heart rate, pressure in wedge-position
(PCWP), pulmonary arterial pressure (PAP) and right
atrium pressure (RAP). O2 saturation (SO2) was mea-
sured in mixed venous blood samples (ABL 725, Radio-
meter, Copenhagen, Denmark). The cardiac output was
measured by thermodilution with 10 ml of sterile, ice-
cold isotonic (0.9%) saline, which was injected through
the right atrial lumen of the catheter; the drop in tem-
perature at the distal thermistor was then recorded. The
injectate temperature was determined by a thermistor
which was placed directly behind the right atrial inlet of
the catheter. Cardiac output was calculated using a
Schwaiblmair et al. Respiratory Research 2012, 13:18
http://respiratory-research.com/content/13/1/18
Page 2 of 8computer system (Com-2, Cardiac Output Computer,
Edwards Lifesciences, Irvine, USA). In each patient, a
minimum of 3 measurements were performed; the mean
value was calculated if the variability of values was less
than 10%. The pulmonary vascular resistance (PVR) was
calculated using a standard formula [PVR = (mean PAP
- PCWP)/cardiac output].
C2H2 Technique
C2H2 uptake was measured by an open-circuit single-
breath, slow-expiration method using a commercially
available system (Vmax spectra 229 D, Sensor Medics,
USA). The precision and the reliability of this system
have been validated by others [5] and the instructions of
the manufacturer were followed in detail. Briefly, the
patients were instructed to breathe through the mouth-
piece of the apparatus. The nostrils were occluded with
a nose clip. The inhaled gas was a mixture of 0.298%
methane, 0.300% carbon monoxide, 0.300% C2H2,
21.100% O2 and 78.002% nitrogen. The manoeuvre
started at end-expiration with a maximal inspiration.
The breath hold time was 1-3 seconds. Then the
patients slowly exhaled the total volume. Thereafter,
cardiac output was calculated by an integrated computer
from the disappearance curve of C2H2. In each patient, a
minimum of 3 measurements were performed; the mean
value was calculated if the variability of values was less
than 10%. The procedure was tolerated without any pro-
blems by all patients.
Statistical Analysis
Statistical analysis was performed with SPSS software for
Windows version 12.0 (SPSS, IBM Inc., Chicago, USA).
All data are presented as mean ± standard error of
mean (SEM). The results obtained from the PAH and
CTEPH group were compared using the Student’s t-test
for unpaired probes. The agreement between the ther-
modilution and C2H2 method was analyzed as described
by Bland and Altman [9]. Agreement bias was expressed
as the mean of the differences obtained by the different
techniques. The limits of agreement were expressed as
the mean ± 2 SD, and the 95% confidence interval (95%
CI) of the bias was calculated. Simple linear regression
analysis was performed in order to compare the quality
of agreement between the cardiac output measurements
obtained by the different techniques in both cohorts. A
probability value of less than 0.05 was considered statis-
tically significant; all reported p values are two-tailed.
Results
Clinical Characteristics of the study population
A total of 104 patients were included in the study
(Table 1). 72 patients were diagnosed having PAH and
32 study participants were suffering from CTEPH.
CTEPH patients were significantly older than subjects in
the PAH subgroup (70.4 ± 1.4 vs. 52.5 ± 2.3 years, p <
0.001). Gender and body mass indices (BMI) were
equally distributed in both groups.
Lung Function Testing
Lung function tests showed no relevant restrictive lung
d i s e a s ei nb o t hg r o u p s( T a b l e1 ) .T h eF E V 1a n dt h e
FEV1/FVC ratios were located on the lower limit of nor-
mal (2.09 ± 0.07 L/s and 70.2 ± 1.0%, respectively) with
significant lower values in the CTEPH group (1.80 ±
0.11 vs. 2.21 ± 0.08 L/s, p = 0.005 and 65.4 ± 2.1 vs.
72.2 ± 1.0%, p = 0.002, respectively).
Hemodynamics
Mean PAP was elevated with 47.0 ± 1.4 mmHg with a
normal PCWP of 8.8 ± 0.3 mmHg in both groups (Table
1). However, the cardiac output and cardiac indices (CI)
were significantly lower in the CTEPH group (3.68 ± 0.18
vs. 4.09 ± 0.14 L/min, p = 0.001 and 2.02 ± 0.09 vs. 2.38
± 0.07 L/min/m
2, p = 0.004, respectively).
CPET
Both groups showed a reduction in work capacity of
51.0 ± 2.5% with a diminished VO2 of 62.9 ± 2.3% (16.0
± 0.6 ml/min/kg), a reduced O2 pulse of 9.3 ± 0.3 ml/
Table 1 Clinical characteristics, lung function testing, and
hemodynamics
All
n = 104
PAH
n=7 2
CETPH
n=3 2
p
Characteristics
Age (years) 58.1 ± 1.8 52.5 ± 2.3 70.4 ± 1.4 < 0.001
Female/male (n) 61/43 47/25 20/12 0.898
BMI (kg/m
2) 25.9 ± 0.5 25.4 ± 0.6 27.4 ± 0.8 0.192
Lung function
FVC (L) 2.98 ± 0.08 3.07 ± 0.10 2.73 ± 0.16 0.285
FVC (%) 89.9 ± 1.6 90.4 ± 1.8 86.9 ± 2.6 0.641
TLC (L) 5.41 ± 0.11 5.37 ± 0.14 5.47 ± 0.19 0.209
TLC (%) 98.1 ± 1.5 98.0 ± 1.8 95.8 ± 2.7 0.880
FEV1 (L/s) 2.09 ± 0.07 2.21 ± 0.08 1.80 ± 0.11 0.005
FEV1/FVC (%) 70.2 ± 1.0 72.2 ± 1.0 65.4 ± 2.1 0.002
TLco (%) 61.0 ± 2.1 59.9 ± 2.7 63.8 ± 2.9 0.943
pO2 at rest (mmHg) 61.2 ± 1.1 63.8 ± 1.4 54.6 ± 1.5 < 0.001
pCO2 at rest (mmHg) 30.6 ± 0.5 29.8 ± 0.6 32.3 ± 0.7 0.015
Hemodynamics
mPAP (mmHg) 47.0 ± 1.4 46.0 ± 1.7 51.1 ± 2.2 0.255
Cardiac output (L/min) 3.96 ± 0.15 4.09 ± 0.14 3.94 ± 0.18 0.001
CI (L/min/m
2) 2.27 ± 0.06 2.38 ± 0.07 2.02 ± 0.09 0.004
PVR (dyne ￿s/cm
5) 791 ± 31 779 ± 37 843 ± 58 0.181
mRAP (mmHg) 7.2 ± 0.5 6.1 ± 0.5 10.0 ± 1.3 0.001
PCWP (mmHg) 8.8 ± 0.3 8.2 ± 0.4 10.6 ± 0.7 0.002
SVO2 (%) 58.3 ± 0.9 58.9 ± 0.9 56.7 ± 1.9 0.527
Data are shown as means ± SEM.
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V C O 2o f4 8 . 3±1 . 0a tt h eA To f1 0 . 4±0 . 4m l / m i n / k g
(Table 2). In addition, we observed an increased AaDO2
of 50.7 ± 1.3 mmHg and an elevated Vd/Vt of 35.8 ±
1.2% during peak exercise with an arterial to end-tidal
CO2 gradient (a-etCO2) of 5.7 ± 0.5 mmHg. Ve/VCO2
slope amounted to 49.6 ± 1.6 with a PetCO2 of 23.9 ±
0.6 mmHg at peak exercise. In comparison to the PAH
group, the Ve/VCO2 was found to be significant higher
in the CTEPH group (51.7 ± 1.4 vs. 47.1 ± 1.3, p =
0.036). In addition, the Vd/Vt and the a-etCO2 were
also significantly elevated among CTEPH patients com-
pared to the PAH subgroup (44.5 ± 1.6 vs. 32.2 ± 1.4%,
p < 0.001 and 9.9 ± 0.8 vs. 4.1 ± 0.5 mmHg, p < 0.001,
respectively).
Comparison of cardiac output measurements by the C2H2
method and thermodilution
The average cardiac output as determined by thermodi-
lution was 3.96 ± 0.15 L/min and 3.68 ± 0.22 L/min by
the C2H2 t e c h n i q u ef o rt h ew h o l es t u d yp o p u l a t i o n .
Among PAH patients, the mean cardiac output was 4.09
± 0.14 L/min measured by thermodilution and 3.94 ±
0.18 L/min evaluated by C2H2 uptake. In the CTEPH
group, mean cardiac output was determined to be 3.68
± 0.18 L/min by thermodilution and 3.10 ± 0.32 L/min
by the C2H2 technique. Figure 1 plots the results
obtained by thermodilution with those obtained by
C2H2 uptake. Figure 2 shows the Bland & Altman plot
of the differences between thermodilution and C2H2
technique against the mean of both values. In PAH
patients the results obtained by the two methods
showed an acceptable agreement with the mean
difference being -0.16 L/min (95% CI -2.64 to 2.32 L/
min). In contrast, the agreement was poorer in the
CTEPH group with the difference being -0.56 L/min
(95% CI -4.96 to 3.84 L/min). Simple linear regression
analysis revealed that values for cardiac output mea-
sured by thermodilution and C2H2 uptake were signifi-
cantly associated in the PAH subgroup (R
2 =0 . 1 2 2 ,p=
0.004). In contrast, cardiac output measurements
obtained by the different techniques in the CTEPH
cohort were not significantly associated (R
2 = 0.032, p =
0.35).
Discussion
Our study revealed an acceptable agreement of the
cardiac output assessment determined by thermodilu-
tion and C2H2 uptake in PAH patients, although we
observed a large splay of single measurements. These
differences, however, were not larger than those
reported from patients with other cardiopulmonary
diseases [10]. Our findings are in accordance with an
earlier trial by Hoeper et al. who reported that thermo-
dilution and C2H2 rebreathing are equally accurate in
patients with idiopathic PAH when being compared
with the direct Fick method [2]. In contrast, our study
demonstrated that the agreement between thermodilu-
tion and the C2H2 technique was poor in patients suf-
fering from CTEPH.
Several issues need to be discussed in this context. In
our study CTEPH patients had lower CI values com-
pared to the PAH subgroup. As C2H2 uptake tends to
underestimate cardiac output in our CTEPH cohort and
thermodilution might overestimate cardiac output in the
presence of a low CI [11], the poorer agreement of both
methods could be explained by a wider divergence of
measurements. However, another trial has challenged
this hypothesis indicating that thermodilution is equally
accurate in a broad spectrum of cardiac output values
[2].
Furthermore, mean FEV1 and the averaged FEV1/FVC
ratios were significantly reduced in the CETPH cohort,
possibly explaining the poorer agreement of both meth-
ods. As patients with concurrent lung diseases were
excluded from our trial and both groups had similar
mean BMI values, these findings might be explained by
the older mean age in the CETPH subgroup. As the
alveolar distribution of C2H2 might be affected by the
reduction of FEV1/FVC, cardiac output measurements
obtained by the C2H2 uptake method are probably less
accurate in the CTEPH cohort.
In addition to that, an impaired gas exchange might
contribute to the poorer agreement of both techniques
in the CTEPH cohort, as the C2H2 technique is
expected to fail in the presence of a relevant mismatch-
ing of ventilation to perfusion. Indeed, we found
Table 2 Cardiopulmonary exercise testing
All
n = 104
PAH
n=7 2
CETPH
n=3 2
p
W (watts) 57.7 ± 3.4 63.4 ± 4.4 44.0 ± 4.6 0.011
W (%) 51.0 ± 2.5 52.8 ± 2.9 43.8 ± 4.6 0.192
VO2 (ml/min) 1111 ± 43 1150 ± 55 1033 ± 69 0.513
VO2 (%) 62.9 ± 2.3 61.2 ± 2.9 66.1 ± 3.9 0.638
VO2 (ml/min/kg) 16.0 ± 0.6 16.7 ± 0.8 14.0 ± 0.9 0.044
AT (ml/min/kg) 10.4 ± 0.4 11.0 ± 0.5 9.1 ± 0.6 0.019
O2 pulse (ml/min/beat) 9.3 ± 0.3 8.9 ± 0.3 10.1 ± 0.6 0.137
Ve (L/min) 61.4 ± 2.0 63.3 ± 2.6 63.3 ± 2.6 0.416
Ve/VO2 41.2 ± 1.0 40.8 ± 1.3 42.3 ± 1.4 0.299
Ve/VCO2 48.3 ± 1.0 47.1 ± 1.3 51.7 ± 1.4 0.036
AaDO2 (mmHg) 50.7 ± 1.3 50.4 ± 1.7 51.5 ± 1.6 0.775
Vd/Vt (%) 35.8 ± 1.2 32.2 ± 1.4 44.5 ± 1.6 < 0.001
a-et CO2 (mmHg) 5.74 ± 0.5 4.1 ± 0.5 9.9 ± 0.8 < 0.001
Ve/VCO2 slope 49.6 ± 1.6 48.6 ± 2.0 53.2 ± 2.3 0.145
RER 1.08 ± 0.01 1.09 ± 0.01 1.05 ± 0.02 0.143
Data are shown as means ± SEM.
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fusion in CTEPH patients primarily due to two different
mechanisms, increased dead space ventilation and het-
erogeneous pulmonary perfusion.
Although there are some reports indicating that venti-
lation/perfusion matching is relatively well preserved in
both conditions [12-14], there is evidence that increased
ventilation/perfusion ratios in CTEPH are primarily
Figure 1 Cardiac output measurements by thermodilution compared with results obtained by the acetylene technique in patients
with pulmonary arterial hypertension (a) and chronic thromboembolic hypertension (b). The solid line represents the bisecting line.
Schwaiblmair et al. Respiratory Research 2012, 13:18
http://respiratory-research.com/content/13/1/18
Page 5 of 8caused by augmented dead space fractions [15,16]. In
our study Vd/Vt at peak exercise was significantly
increased in CTEPH compared to PAH. These findings
are in accordance with the report of Zhai and collea-
gues, who were able to show that significant differences
in gas exchange exist between CTEPH and PAH due to
differences in Vd/Vt [7]. Dead space ventilation in pul-
monary thromboembolism increases the gradient
between arterial and end-tidal CO2 [17]. Correspond-
ingly, we found the mean a-etCO2 gradient to be signifi-
cantly elevated among CTEPH patients compared to the
PAH subgroup in our study. Similar findings have
recently been made by Scheidl and co-workers [18], who
found increased capillary to end-tidal CO2 differences in
patients with CTEPH compared to those suffering from
idiopathic PAH. Increased dead space ventilation might
be the result of a more uneven perfusion pattern in
CTEPH patients, possibly due to additional thrombus
formation and a more proximal vascular occlusion, lead-
ing to heterogeneous perfusion defects [19]. Areas with
diminished blood flow and areas with increased blood
flow coexist, while ventilation is more or less homoge-
neously distributed. As a result, there are areas with an
increased ventilation/perfusion ratio or even dead space
Figure 2 Individual differences in cardiac output between thermodilution and acetylene uptake in patients with pulmonary arterial
hypertension (a) and chronic thromboembolic hypertension (b), plotted against the average corresponding values (L/min). The solid
line represents the mean or bias of the differences; the dashed lines represent the upper and normal limits of agreement.
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ratio. In contrast, PAH is characterized by an obstruc-
tive vasculopathy that bilaterally involves distal, medium
to small size muscular arteries [20], possibly resulting in
a more balanced distribution of perfusion and ventila-
tion. Therefore, we speculate that compared to PAH
patients, increased heterogeneity in pulmonary blood
flow in comparison to ventilation might contribute to
an inaccurate determination of cardiac output by the
C2H2 method in CTEPH.
Our study is limited by the fact that cardiac output
measurements determined by thermodilution and the
C2H2 method were not performed simultaneously. Thus,
the splay of single measurements might partially be
explained by the physiological variations of cardiac out-
put during the day. However, both techniques were per-
formed shortly after each other without any change of
medication in all study participants in order to minimize
substantial fluctuations. Moreover, the results might
have been influenced by different body positions, as
right heart catheterizations were performed in supine
position while patients were sitting when the C2H2 tech-
nique was performed. Thus, measurements by the C2H2
uptake method might tend to underestimate cardiac
output, as preload decreases when subjects sit up. This
circumstance possibly explains some of the very low car-
diac output values measured by C2H2 uptake. Finally, we
didn’t evaluate the degree of tricuspid regurgitation,
which is commonly present in patients with PH and
might have influenced the accuracy of thermodilution in
our study participants [21]. As a consequence, thermo-
dilution might have underestimated the cardiac output
in the presence of severe tricuspid regurgitation.
Conclusions
Despite these limitations we conclude the following: in
contrast to PAH, the agreement of cardiac output mea-
surements determined by the thermodilution and the
C2H2 uptake method is poorer in CTEPH. The evalua-
tion of cardiac output by the C2H2 technique should be
interpreted with caution in CTEPH patients, as ventila-
tion to perfusion mismatching might be more relevant
in CTEPH than in PAH.
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